GOSSE B. BRUINSMA, M.D.

Corporate Board Profile

Tech Score: 0/100

GT Biopharma, Inc.

Filing Date	Source Excerpt
2004-04-29	Gosse B. Bruinsma, M.D. Age: 49 Director. Dr. Bruinsma was appointed to the Board of Directors as part of the Understanding described above in the section of this Proxy Statement entitled Change In Control. ... After the resignations of Messrs. Ford Webb and Pryor, the Board appointed Dr. Bruinsma and Dr. Ferris as new members of this Committee, such that the Committee is currently comprised of Mr. Davis (Chair), Dr. Bruinsma and Dr. Ferris. ... After the resignations of Messrs. Wolf and Ford Webb, the Board of Directors appointed Dr. Bruinsma and Mr. Neill as new members of this Committee, such that the Committee is currently comprised of Dr. Bruinsma (Chair), Mr. Neill and Dr. Rodell.

Filing Date

Source Excerpt

2004-04-29

Gosse B. Bruinsma, M.D. Age: 49 Director. Dr. Bruinsma was appointed to the Board of Directors as part of the Understanding described above in the section of this Proxy Statement entitled Change In Control. ... After the resignations of Messrs. Ford Webb and Pryor, the Board appointed Dr. Bruinsma and Dr. Ferris as new members of this Committee, such that the Committee is currently comprised of Mr. Davis (Chair), Dr. Bruinsma and Dr. Ferris. ... After the resignations of Messrs. Wolf and Ford Webb, the Board of Directors appointed Dr. Bruinsma and Mr. Neill as new members of this Committee, such that the Committee is currently comprised of Dr. Bruinsma (Chair), Mr. Neill and Dr. Rodell.

Data sourced from SEC filings. Last updated: 2025-08-30